PRN: In Vitro Toxicity Testing Market is Expected to Reach $7,813 Million by 2022, Globally - Allied Market Research

12/gen/2017 17:30:28 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

In Vitro Toxicity Testing Market is Expected to Reach $7,813 Million by 2022, Globally - Allied Market Research

 
[12-January-2017]
 

PORTLAND, Oregon and Pune, India, January 12, 2017 /PRNewswire/ --

A new report published by Allied Market Research titled, "Global In vitro Toxicity Testing Market by Type and End Users - Global Opportunity Analysis and Industry Forecast, 2014-2022," projects that the global in vitro toxicity testing market would reach $7,813 million by 2022 from $2,921 million in 2015, growing at a CAGR of 15.07% during the forecast period.

     (Logo: http://photos.prnewswire.com/prnh/20140911/647229 )

Need more information: https://www.alliedmarketresearch.com/in-vitro-toxicity-testing-market

Testing for presence of toxic compounds is an important step during the development of new products such as drugs, cosmetics, and food additives, which can save both time and developmental costs as well as reduce the probability of failure during later stages. In vitro toxicity testing is a procedure that helps examine the presence of these toxic compounds over an isolated part of the organism. The increase in number of R&D procedures, which require in vitro testing, ban on animal testing, and increase in awareness about the environmental concerns can boost the market growth.

According to Hemali Narkhede, Research Analyst at Allied Market Research "Cosmetics and household products segment would be the most lucrative segment for investment in the in vitro toxicity testing market for the new as well as existing players. This is attributed to the increasing demand for safe cosmetics and household products."

Absorption screening dominated the global in vitro toxicity testing market in 2015 and is expected to continue with its dominance throughout the forecast period. This can be attributed to the various applications of absorption screening pharmaceutical, cosmetics, and household products. However, toxic substances screening in IVTT is expected to be the fastest growing segment due to the increase in cases of lead poisoning and cancers that occur due to the mutation caused by the toxic chemicals, registering a CAGR of 15.85%.

Cosmetics and household products segment is the highest revenue contributor to this market owing to increase in adoption in various applications, such as to detect dermal toxicity, systemic toxicity, and ocular toxicity. However, food industry is expected to be the fastest growing segment owing to the high demand in U.S., China, and India, growing at a CAGR of 19.65%.

Presently, North America and Europe have the highest growth potential due to technological advancements and increased R&D initiatives in these regions. However, the market would gain traction in the developing regions of Asia-Pacific, due to the increase in urbanization & disposable income, rise in government funding, and growth in awareness about the advanced technologies. India and China are expected to be the fastest growing regions in the global in vitro toxicity testing market.

Summary of Similar Reports can be viewed at: https://www.alliedmarketresearch.com/life-sciences/diagnostic-and-biotech-market-report

KEY FINDINGS OF IN VITRO TOXICITY TESTING MARKET: 

  • Cosmetics and household products segment is the highest revenue contributor throughout the analysis period.
  • Food industry segment is estimated to exhibit a CAGR of 19.65%, among the end users.
  • Asia-Pacific is expected to be the fastest growing segment during the forecast period.
  • U.S. was the largest economy market in 2015, and is projected to maintain its lead until 2022.

The key players profiled in this report include Agilent Technologies, Inc., BioReliance, Inc., Alere, Inc., Charles River Laboratories International, Inc., General Electric Company, Covance, Inc., Catalent, Inc., Eurofins Scientific, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific, Inc.

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. The data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact
Pankaj Kumar
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com

Website: https://www.alliedmarketresearch.com


blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl